Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases Mingming SunWei WuYingzi Cong Review 23 July 2016 Pages: 1 - 8
Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan Tetsuhide ItoSusumu HijiokaMasayuki Imamura Review 18 August 2016 Pages: 9 - 18
Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review Laura MartelliPablo OliveraLaurent Peyrin-Biroulet Review 24 September 2016 Pages: 19 - 25
Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis Haruhiko TakedaAtsushi TakaiHiroyuki Marusawa Review 06 October 2016 Pages: 26 - 38
SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer Osmel Companioni NápolesAmy C. TsaoJuanita L. Merchant Original Article—Alimentary Tract 31 March 2016 Pages: 39 - 49
A prospective, multicenter survey on the validity of shorter periendoscopic cessation of antithrombotic agents in Japan Katsuhiro MabeMototsugu KatoThe Sapporo Consensus Study Group Original Article—Alimentary Tract 16 April 2016 Pages: 50 - 60
Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling Kenichi YoshikawaChie KuriharaRyota Hokari Original Article—Alimentary Tract 13 April 2016 Pages: 61 - 71
Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats Tsukasa NozuSaori MiyagishiToshikatsu Okumura Original Article—Alimentary Tract 13 April 2016 Pages: 72 - 80
Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting Tsutomu FujiiSohei SatoiYasuhiro Kodera Original Article—Liver, Pancreas, and Biliary Tract 11 May 2016 Pages: 81 - 93
Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1 Etsuko IioNoritomo ShimadaYasuhito Tanaka Original Article—Liver, Pancreas, and Biliary Tract 28 May 2016 Pages: 94 - 103
Prediction of development of hepatocellular carcinoma using a new scoring system involving virtual touch quantification in patients with chronic liver diseases Tomoko AokiHiroko IijimaShuhei Nishiguchi Original Article—Liver, Pancreas, and Biliary Tract 15 June 2016 Pages: 104 - 112
The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study Takashi TaidaMakoto AraiOsamu Yokosuka Original Article—Liver, Pancreas, and Biliary Tract 15 June 2016 Pages: 113 - 122
A novel intestinal organoid-based in vitro co-culture system to dissect out the initial host defense system Atsushi Mizoguchi Editorial 23 July 2016 Pages: 123 - 124
Treatment of HCV patients on hemodialysis with daclatasvir and asunaprevir Kazuaki ChayamaClair Nelson Hayes Editorial 19 August 2016 Pages: 125 - 126
Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B Akihiro Matsumoto Editorial 24 September 2016 Pages: 127 - 128